Literature DB >> 31815601

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2019        PMID： 31815601      PMCID： PMC6930097          DOI： 10.1080/21645515.2019.1691423

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  9 in total

1.  Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.

Authors:  Rita Kansal; Noah Richardson; Indira Neeli; Saleem Khawaja; Damian Chamberlain; Marium Ghani; Qurat-Ul-Ain Ghani; Louisa Balazs; Sarka Beranova-Giorgianni; Francesco Giorgianni; James N Kochenderfer; Tony Marion; Lorraine M Albritton; Marko Radic
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

2.  RIG-I activation is critical for responsiveness to checkpoint blockade.

Authors:  Simon Heidegger; Alexander Wintges; Florian Stritzke; Sarah Bek; Katja Steiger; Paul-Albert Koenig; Sascha Göttert; Thomas Engleitner; Rupert Öllinger; Tatiana Nedelko; Julius C Fischer; Vladimir Makarov; Christof Winter; Roland Rad; Marcel R M van den Brink; Jürgen Ruland; Florian Bassermann; Timothy A Chan; Tobias Haas; Hendrik Poeck
Journal:  Sci Immunol       Date:  2019-09-13

3.  Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens.

Authors:  Michael J Mina; Tomasz Kula; Yumei Leng; Mamie Li; Rory D de Vries; Mikael Knip; Heli Siljander; Marian Rewers; David F Choy; Mark S Wilson; H Benjamin Larman; Ashley N Nelson; Diane E Griffin; Rik L de Swart; Stephen J Elledge
Journal:  Science       Date:  2019-11-01       Impact factor: 47.728

4.  Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles.

Authors:  Velislava N Petrova; Bevan Sawatsky; Alvin X Han; Brigitta M Laksono; Lisa Walz; Edyth Parker; Kathrin Pieper; Carl A Anderson; Rory D de Vries; Antonio Lanzavecchia; Paul Kellam; Veronika von Messling; Rik L de Swart; Colin A Russell
Journal:  Sci Immunol       Date:  2019-11-01

5.  Broadly protective human antibodies that target the active site of influenza virus neuraminidase.

Authors:  Daniel Stadlbauer; Xueyong Zhu; Meagan McMahon; Jackson S Turner; Teddy J Wohlbold; Aaron J Schmitz; Shirin Strohmeier; Wenli Yu; Raffael Nachbagauer; Philip A Mudd; Ian A Wilson; Ali H Ellebedy; Florian Krammer
Journal:  Science       Date:  2019-10-25       Impact factor: 47.728

6.  Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses.

Authors:  Xiaodong Jiang; Viswanathan Muthusamy; Olga Fedorova; Yong Kong; Daniel J Kim; Marcus Bosenberg; Anna Marie Pyle; Akiko Iwasaki
Journal:  J Exp Med       Date:  2019-10-10       Impact factor: 14.307

7.  Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity.

Authors:  Guangchuan Wang; Ryan D Chow; Zhigang Bai; Lvyun Zhu; Youssef Errami; Xiaoyun Dai; Matthew B Dong; Lupeng Ye; Xiaoya Zhang; Paul A Renauer; Jonathan J Park; Li Shen; Hanghui Ye; Charles S Fuchs; Sidi Chen
Journal:  Nat Immunol       Date:  2019-10-14       Impact factor: 25.606

8.  Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform.

Authors:  Eytan Herzig; Kaman Chan Kim; Thomas A Packard; Noam Vardi; Roland Schwarzer; Andrea Gramatica; Steven G Deeks; Steven R Williams; Kyle Landgraf; Nigel Killeen; David W Martin; Leor S Weinberger; Warner C Greene
Journal:  Cell       Date:  2019-10-24       Impact factor: 41.582

9.  A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice.

Authors:  Armine Hovakimyan; Tatevik Antonyan; Sepideh Kiani Shabestari; Olga Svystun; Gor Chailyan; Morgan A Coburn; William Carlen-Jones; Irina Petrushina; Jean Paul Chadarevian; Karen Zagorski; Nikolai Petrovsky; David H Cribbs; Michael G Agadjanyan; Anahit Ghochikyan; Hayk Davtyan
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.